Cryotherapy versus topical nitric-zinc complex solution for the treatment of plantar warts: A randomized controlled trial

Cryotherapy is commonly regarded as the primary treatment method for plantar warts. A new medical device called nitric-zinc complex solution (NZCS) has also emerged as a potential alternative for wart treatment. The main aim of this study was to analyze and compare the effectiveness of cryotherapy using liquid nitrogen and NZCS in treating plantar warts. We conducted a randomized and controlled clinical trial involving patients with plantar warts. A total of 62 patients were enrolled in the study and monitored for 12 weeks or until their warts were completely resolved. The patients received either cryotherapy or NZCS, with a maximum of six treatment applications. The cure rate was 65.5% in the group treated with cryotherapy and 56.6% in the group treated with NZCS. The average number of treatment applications required for curing warts was significantly lower in the cured group (3.28 +/- 1.63) than in the group with unresolved warts (5.5 +/- 1.27) (p<0.01). Moreover, the average number of applications was lower in the cryotherapy group (3.6 +/- 1.8) than in the NZCS group (4.8 +/- 1.8) (p<0.01). Based on the findings, NZCS could be considered a favorable first-line treatment option for plantar warts.